NASDAQ:MNKD
MannKind Corporation Stock News
$4.39
+0.0100 (+0.228%)
At Close: May 03, 2024
MannKind files for $50M mixed shelf offering
10:44pm, Thursday, 24'th Feb 2022 Seeking Alpha
MannKind Corp. (MNKD) has filed for a $50M mixed shelf offering.
MannKind earnings miss on top and bottom lines, capping 20% daily loss
09:57pm, Thursday, 24'th Feb 2022 Seeking Alpha
MannKind (MNKD) Q4 2021 earnings missed on both the top and bottom lines, adding more misery on a day the stock closed down more than 20%.
MannKind's (MNKD) CEO Michael Castagna on Q4 2021 Results - Earnings Call Transcript
09:37pm, Thursday, 24'th Feb 2022
MannKind's (MNKD) CEO Michael Castagna on Q4 2021 Results - Earnings Call Transcript
MannKind Non-GAAP EPS of -$0.11 misses by $0.05, revenue of $12.52M misses by $4.59M
09:03pm, Thursday, 24'th Feb 2022 Seeking Alpha
MannKind press release (MNKD): Q4 Non-GAAP EPS of -$0.11 misses by $0.05.Revenue of $12.52M (-32.1% Y/Y) misses by $4.59M.“We had a solid fourth quarter with Afrezza net revenue…
MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial Results
09:00pm, Thursday, 24'th Feb 2022 GlobeNewswire
Conference Call to Begin Today at 5:00 p.m. (ET)
FDA Pushes United Therapeutics-MannKind Tyvaso DPI''s Decision Date; United Therapeutics'' Q4 Misses Consensus
12:03pm, Thursday, 24'th Feb 2022 Benzinga
United Therapeutics Corp (NASDAQ: UTHR ) and its partner MannKind Corp (NASDAQ: MNKD ) have received an FDA information request letter for additional information regarding the pulmonary safety of Tyvaso DPI . United Therapeutics responded to the agency''s information request. However, the FDA has considered this response to be a significant amendment to the NDA, extending FDA''s review deadline to May 2022 … Full story available on Benzinga.com
MannKind says FDA extends deadline to review Tyvaso DPI
11:38am, Thursday, 24'th Feb 2022 Seeking Alpha
MannKind (MNKD) said the U.S. Food and Drug Administration ((FDA)) has extended its deadline to May from February to review United Therapeutics'' (UTHR) new drug application ((NDA))…
Update on Tyvaso DPI™ New Drug Application
11:05am, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic
MannKind Q4 2021 Earnings Preview
10:35pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
MannKind (NASDAQ:MNKD) is scheduled to announce Q4 earnings results on Thursday, Feb. 24, after market close.The consensus EPS estimate is -$0.06 (flat Y/Y)
MannKind Corporation to Hold 2021 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2022
02:05pm, Monday, 21'st Feb 2022 GlobeNewswire Inc.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2021 fourth quarter and full year financial results, and its manag
MannKind Corporation to Hold 2021 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2022
09:05am, Monday, 21'st Feb 2022
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 21, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2021 fourth quarter and full year financial results, and its managem
5 ‘Must Watch’ Penny Stocks For February 2022
05:43pm, Sunday, 13'th Feb 2022 PennyStocks
5 must watch penny stocks that you should know about in February
The post 5 ‘Must Watch’ Penny Stocks For February 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt
5 ‘Must Watch' Penny Stocks For February 2022
12:43pm, Sunday, 13'th Feb 2022
5 must watch penny stocks that you should know about in February The post 5 ‘Must Watch' Penny Stocks For February 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStoc
MannKind Corporation to Participate in SVB Leerink 2022 Global Healthcare Conference
11:05am, Thursday, 10'th Feb 2022 GlobeNewswire Inc.
DANBURY, Conn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with en
MannKind Corporation to Participate in SVB Leerink 2022 Global Healthcare Conference
06:05am, Thursday, 10'th Feb 2022
DANBURY, Conn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endo